Treatment of latent tuberculosis with 12 weeks isoniazid/rifapentine in clinical practice

被引：6
|
作者：
Froberg, Gabrielle [1 ,2 ]
Jansson, Lena [1 ]
Bruchfeld, Judith [1 ,2 ]
机构：
[1] Karolinska Univ Hosp, Dept Infect Dis, B2 00, S-17176 Stockholm, Sweden
[2] Karolinska Inst, Div Infect Dis, Dept Med Solna, Stockholm, Sweden
来源：
EUROPEAN RESPIRATORY JOURNAL | 2019年 / 53卷 / 02期
关键词：
INFECTION; RIFAPENTINE;
D O I：
10.1183/13993003.01128-2018
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Severe hypertension after initiation of rifapentine/isoniazid for latent tuberculosis in renal transplant candidates
    Simkins, Jacques
    Morris, Michele I.
    Abbo, Lilian M.
    Camargo, Jose F.
    TRANSPLANT INTERNATIONAL, 2017, 30 (01) : 108 - 109
  • [22] Low isoniazid concentrations and outcome of tuberculosis treatment with once-weekly isoniazid and rifapentine
    Weiner, M
    Burman, W
    Vernon, A
    Benator, D
    Peloquin, CA
    Khan, A
    Weis, S
    King, B
    Shah, N
    Hodge, T
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (10) : 1341 - 1347
  • [23] Isoniazid-Rifapentine for Latent Tuberculosis Infection: A Systematic Review and Meta-analysis
    Njie, Gibril J.
    Morris, Sapna Bamrah
    Woodruff, Rachel Yelk
    Moro, Ruth N.
    Vernon, Andrew A.
    Borisov, Andrey S.
    AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2018, 55 (02) : 244 - 252
  • [24] Use of rifapentine and isoniazid for latent TB in Australia
    Chang, V
    Fox, G.
    RESPIROLOGY, 2023, 28 : 227 - 227
  • [25] Genetic and clinical predictors of rifapentine and isoniazid pharmacokinetics in paediatrics with tuberculosis infection
    Phaisal, Weeraya
    Albitar, Orwa
    Chariyavilaskul, Pajaree
    Jantarabenjakul, Watsamon
    Wacharachaisurapol, Noppadol
    Ghadzi, Siti Maisharah Sheikh
    Zainal, Hadzliana
    Harun, Sabariah Noor
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2024, 79 (06) : 1270 - 1278
  • [26] Role of isoniazid in once-weekly rifapentine treatment of pulmonary tuberculosis
    Mitchison, DA
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2003, 167 (10) : 1298 - 1299
  • [27] SAFETY AND ADHERENCE FOR 12 WEEKLY DOSES OF ISONIAZID AND RIFAPENTINE FOR PEDIATRIC TUBERCULOSIS INFECTION
    Cruz, Andrea T.
    Starke, Jeffrey R.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2016, 35 (07) : 811 - 813
  • [28] The Cost To Implement A 12-Dose Weekly Isoniazid And Rifapentine (3hp) Regimen For Latent Tuberculosis Infection (ltbi)
    Marks, S. M.
    Sandul, A.
    Shah, N.
    Nwana, N.
    Mukasa, L.
    Bertsch, T.
    Ho, C.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2017, 195
  • [29] Assessment for Antibodies to Rifapentine and Isoniazid in Persons Developing Flu-Like Reactions During Treatment of Latent Tuberculosis Infection
    Moro, Ruth N.
    Mehaffy, Carolina
    De, Prithwiraj
    Phillips, Elizabeth
    Borisov, Andrey S.
    Sterling, Timothy R.
    Dobos, Karen M.
    JOURNAL OF INFECTIOUS DISEASES, 2024, 230 (05): : 1271 - 1278
  • [30] Treatment completion for latent tuberculosis infection: a retrospective cohort study comparing 9 months of isoniazid, 4 months of rifampin and 3 months of isoniazid and rifapentine
    McClintock, Adelaide H.
    Eastment, McKenna
    McKinney, Christy M.
    Pitney, Caroline L.
    Narita, Masahiro
    Park, David R.
    Dhanireddy, Shireesha
    Molnar, Alexandra
    BMC INFECTIOUS DISEASES, 2017, 17
12345